High Dropout Rates Raise Concerns Over Weight-Loss Drugs' Effectiveness
A population study in Denmark found that over half of adults without diabetes who start the weight-loss drug semaglutide discontinue it within a year, mainly due to high costs, adverse effects, and demographic factors, raising concerns about long-term effectiveness and accessibility of this obesity treatment.
